Khalid Z. Al Shali MBChB (Hon), M.Sc., ABIM, ABEM, FRCP(C), FACP
Professor and Consultant, Endocrinology
Diabetes and Endocrine Centre of Excellence
Years of Experience: 20
Education
Medical School
1994
Bachelor’s Degree in Medicine and Surgery
King Abdulaziz University in Jeddah, KSA
Medical School
2004
Master’s Degree in Biochemistry
University of Western Ontario, Canada
Residency
1997 - 2000
Residency: Internal Medicine,
University of Western Ontario (UWO)
Fellowships
Fellowship
2000 - 2002
Fellowship Endocrinology and Metabolism
University of Western Ontario (UWO)
Fellowship
2002 - 2004
strategic training fellow in vascular research
Canadian Institutes of Health Research (CIHR)
License
- Saudi Commission for Health specialties
Work Experience
2007 – Present
Consultant, Endocrinology
International Medical Centre in Jeddah, KSA
2017 – Present
Professor of Medicine and Endocrinology
King Abdulaziz University, KSA
2000
Internal medicine
American Board
Endocrinology diabetes and metabolism
American Board
Achievements & Career Highlights
- Consultant endocrinologist since 2004.
- Professor of Medicine and Endocrinology since 2021.
- American Board Internal Medicine certified in 2000.
- Royal College of Physicians and Surgeons of Canada Internal Medicine certified in 2001.
- Fellow of the Royal College of Physicians and Surgeons of Canada in the division of Medicine since 2001.
- American Board Endocrinology certified in 2002.
- Royal College of Physicians and Surgeons of Canada Endocrinology certified in 2002.
- Fellow of the American College of Physicians, 2004.
- Program Director of the SCHS Diabetes Subspecialty Fellowship Program at King Abdulaziz University Hospital from March 2018 to present
Publications
- Successful pregnancy outcome in a patient with severe chylomicronemia due to compound heterozygosity for mutant lipoprotein lipase. Clin Biochem. 2002 Mar;35(2):125-130.
- Management of severe hypertriglyceridemia in pregnancy. University of Western Ontario Medical Journal. 2003; 72(2):12-14.
- Laminopathies and atherosclerosis. Arterioscler Thromb Vasc Biol. 2004 Sep;24(9):1591-5.
- Genetic variation in PPARG encoding peroxisome proliferator-activated receptor gamma associated with carotid atherosclerosis. Stroke. 2004 Sep; 35(9):2036-40.
- A single base mutation in the PPAR?4 promoter associated with altered in vitro expression and partial lipodystrophy. J Clin Endocrinol Metab. 2004 Nov;89(11):5655-60.
- Hypertriglyceridemia: its etiology, effects and treatment. CMAJ. 2007 Apr 10;176(8):1113-20
- Iodine Deficiency Among Hypothyroid Patients Living in Jeddah. Biol Trace Elem Res. 2009, 130: 193-203.
- Prevalence of hyper- and hypoglycemia among adult inpatients at a university hospital in Saudi Arabia. Journal of King Abdulaziz University – Medical Sciences. 2014. Volume 21 (4), 25-37.
- A review of glycemic efficacy of liraglutide once daily in achieving glycated hemoglobin targets compared with exenatide twice daily, or sitagliptin once daily inthe treatment of type 2 diabetes. Saudi Med J. 2016 Aug; 37(8):834-42.
- The covariant CDKN2A/B rs10811661 (C/T) gene polymorphism is associated with increased risk of type 2 diabetes mellitus in a Saudi Arabian population. Middle East Journal of Medical Genetics. 2018,7:19–25.
- Association between type 2 diabetes mellitus and hypothyroidism: a case-control study. Int J Gen Med. 2018 Dec 4;11:457-461.
- Knowledge, Attitudes, and Practices of COVID-19 Safety Measures Among Type 1 Diabetes Mellitus Patients at King Abdulaziz University Hospital: A Cross-Sectional Study. Cureus 2022. 14(8): e27713.
- Clinical Practice Guideline for the Management of Overweight and Obesity in Adults in Saudi Arabia. International Journal of Clinical Medicine, 2022. 13, 590-649.
- Roadmap for the Management of Type 2 Diabetes and Hypertension in the Middle East: Review of the 2022 EVIDENT Summit. Adv Ther. 2023. 40:2965–2984
Get the Right Care For You & Your Family
